Hospital Dia do Pulmão

Blumenau, Santa Catarina 89030-101

0 studies enrolling now · 5 studies all time

What they study most

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Covid-19, Idiopathic Pulmonary Fibrosis, Pulmonary Arterial Hypertension, Pulmonary Hypertension

Studies at this site

• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early
• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
• CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients — Stopped early